EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nano-Engineered Smart Biomaterials for Regenerative Medicine, Controlled Drug Delivery, and Precision Therapeutic Applications

Hamid Raleigh, Finbar Slevin

Frontora · 2023

DOI: 10.70945/f.v01i01.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontora, 2023. Verfasst von Hamid Raleigh und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Nano-engineered smart biomaterials integrate biofunctional design and adaptive nanotechnology to achieve controlled drug release, tissue regeneration, and precision-targeted therapeutic modulation within complex physiological environments.

Objective

To evaluate the physicochemical performance, biocompatibility, drug-release kinetics, and regenerative potential of nano-engineered polymer–metal hybrid biomaterials optimized for responsive therapeutic delivery and tissue integration under dynamic physiological conditions.

Methods

This experimental investigation, conducted at the Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, USA (January 2022–June 2023; n = 172), employed sol–gel synthesis, electron microscopy (SEM, TEM), FTIR spectroscopy, and differential scanning calorimetry for characterization. Cellular assays (MTT, ALP, ROS) and dynamic drug-diffusion models quantified cytocompatibility, bioactivity, degradation kinetics, and pH-triggered release profiles. Statistical analysis used ANOVA and post-hoc Tukey tests (SPSS v26.0, p < 0.05).

Results

Mean nanoparticle diameter was 118.6 ± 9.3 nm with < 8 % polydispersity. Surface zeta potential shifted from –21.4 ± 2.6 mV to –9.8 ± 1.7 mV after PEGylation (p = 0.001). Drug-loading efficiency reached 92.4 ± 3.1 %, and cumulative release at pH 5.5 was 84.6 ± 4.8 % vs 46.7 ± 5.2 % at pH 7.4 (p < 0.001). Viability of mesenchymal stem cells increased 38.5 % (± 6.2, p = 0.002), and ROS production decreased 27.1 % (± 4.3, p = 0.004). Compressive strength improved 41.9 ± 3.7 MPa (p = 0.012), while degradation half-life extended from 9.2 ± 0.8 to 14.7 ± 1.1 days (p < 0.001). Adaptive responsiveness to magnetic and thermal stimuli increased drug diffusion coefficient from 2.4 × 10⁻⁶ to 3.9 × 10⁻⁶ cm²s⁻¹.

Conclusion

Nano-engineered polymer–metal hybrids demonstrated superior biocompatibility, tunable degradation, and stimuli-responsive delivery, establishing an advanced platform for regenerative and precision medicine through intelligent, environment-adaptive therapeutic modulation.

Zitieren

APA

Raleigh, H., & Slevin, F. (2023). Nano-Engineered Smart Biomaterials for Regenerative Medicine, Controlled Drug Delivery, and Precision Therapeutic Applications. Frontora. https://doi.org/10.70945/f.v01i01.005

Vancouver

Raleigh H, Slevin F. Nano-Engineered Smart Biomaterials for Regenerative Medicine, Controlled Drug Delivery, and Precision Therapeutic Applications. Frontora. 2023. doi:10.70945/f.v01i01.005

BibTeX
@article{Raleigh2023,
  author = {Raleigh, Hamid and Slevin, Finbar},
  title = {Nano-Engineered Smart Biomaterials for Regenerative Medicine, Controlled Drug Delivery, and Precision Therapeutic Applications},
  journal = {Frontora},
  year = {2023},
  doi = {10.70945/f.v01i01.005}
}
Kostenlos starten →